Balchem Corporation

Informe acción NasdaqGS:BCPC

Capitalización de mercado: US$4.9b

Balchem Dirección

Dirección controles de criterios 4/4

El CEO de Balchem's es Ted Harris , nombrado en Apr 2015, tiene una permanencia de 9.08 años. compensación anual total es $5.89M, compuesta por 19.6% salario y 80.4% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.21% de las acciones de la empresa, por valor de $9.39M. La antigüedad media del equipo directivo y de la junta directiva es de 2 años y 5.5 años, respectivamente.

Información clave

Ted Harris

Chief Executive Officer (CEO)

US$5.9m

Compensación total

Porcentaje del salario del CEO19.6%
Permanencia del CEO9.1yrs
Participación del CEO0.2%
Permanencia media de la dirección2yrs
Promedio de permanencia en la Junta Directiva5.5yrs

Actualizaciones recientes de la dirección

Recent updates

Balchem Corporation's (NASDAQ:BCPC) Popularity With Investors Is Clear

Mar 21
Balchem Corporation's (NASDAQ:BCPC) Popularity With Investors Is Clear

Is Balchem Corporation (NASDAQ:BCPC) Expensive For A Reason? A Look At Its Intrinsic Value

Mar 05
Is Balchem Corporation (NASDAQ:BCPC) Expensive For A Reason? A Look At Its Intrinsic Value

Balchem: Potential Turnaround Is In The Price

Feb 21

These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Reasonably Well

Feb 18
These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Reasonably Well

Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled

Jan 03
Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled

Balchem Corporation's (NASDAQ:BCPC) P/E Is On The Mark

Dec 19
Balchem Corporation's (NASDAQ:BCPC) P/E Is On The Mark

Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Nov 20
Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Balchem (NASDAQ:BCPC) Has A Pretty Healthy Balance Sheet

Oct 19
Balchem (NASDAQ:BCPC) Has A Pretty Healthy Balance Sheet

The Returns At Balchem (NASDAQ:BCPC) Aren't Growing

Sep 09
The Returns At Balchem (NASDAQ:BCPC) Aren't Growing

A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Aug 22
A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Is Balchem (NASDAQ:BCPC) A Risky Investment?

Jul 19
Is Balchem (NASDAQ:BCPC) A Risky Investment?

Some Investors May Be Worried About Balchem's (NASDAQ:BCPC) Returns On Capital

May 28
Some Investors May Be Worried About Balchem's (NASDAQ:BCPC) Returns On Capital

Calculating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

May 12
Calculating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?

Apr 12
Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?

We Think Balchem (NASDAQ:BCPC) Can Stay On Top Of Its Debt

Mar 14
We Think Balchem (NASDAQ:BCPC) Can Stay On Top Of Its Debt

Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns

Jan 11
Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns

Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching

Dec 29
Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching

Is Balchem (NASDAQ:BCPC) A Risky Investment?

Dec 13
Is Balchem (NASDAQ:BCPC) A Risky Investment?

Balchem Corporation (NASDAQ:BCPC) Shares Could Be 26% Above Their Intrinsic Value Estimate

Nov 29
Balchem Corporation (NASDAQ:BCPC) Shares Could Be 26% Above Their Intrinsic Value Estimate

Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return

Sep 20
Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return

Balchem: Acquisitions And Cost Pressures Draw Attention

Sep 12

Balchem (NASDAQ:BCPC) Seems To Use Debt Rather Sparingly

Sep 05
Balchem (NASDAQ:BCPC) Seems To Use Debt Rather Sparingly

Balchem to acquire Cardinal Associates or Bergstrom Nutrition

Aug 30

Is Balchem Corporation (NASDAQ:BCPC) Worth US$138 Based On Its Intrinsic Value?

Aug 22
Is Balchem Corporation (NASDAQ:BCPC) Worth US$138 Based On Its Intrinsic Value?

Should You Be Adding Balchem (NASDAQ:BCPC) To Your Watchlist Today?

Aug 08
Should You Be Adding Balchem (NASDAQ:BCPC) To Your Watchlist Today?

Balchem Q2 2022 Earnings Preview

Jul 28

Balchem: On The M&A Road Again

Jun 28

Balchem: A New Growth Stage Is Just Beginning

Jun 02

Slowing Rates Of Return At Balchem (NASDAQ:BCPC) Leave Little Room For Excitement

May 30
Slowing Rates Of Return At Balchem (NASDAQ:BCPC) Leave Little Room For Excitement

Balchem Corporation's (NASDAQ:BCPC) Intrinsic Value Is Potentially 17% Below Its Share Price

May 18
Balchem Corporation's (NASDAQ:BCPC) Intrinsic Value Is Potentially 17% Below Its Share Price

Does Balchem (NASDAQ:BCPC) Deserve A Spot On Your Watchlist?

May 02
Does Balchem (NASDAQ:BCPC) Deserve A Spot On Your Watchlist?

Does Balchem (NASDAQ:BCPC) Have A Healthy Balance Sheet?

Mar 28
Does Balchem (NASDAQ:BCPC) Have A Healthy Balance Sheet?

Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns

Feb 26
Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns

Balchem (NASDAQ:BCPC) Could Easily Take On More Debt

Dec 23
Balchem (NASDAQ:BCPC) Could Easily Take On More Debt

Return Trends At Balchem (NASDAQ:BCPC) Aren't Appealing

Nov 18
Return Trends At Balchem (NASDAQ:BCPC) Aren't Appealing

We Think Balchem (NASDAQ:BCPC) Can Manage Its Debt With Ease

Sep 22
We Think Balchem (NASDAQ:BCPC) Can Manage Its Debt With Ease

Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return

Aug 16
Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return

Balchem: Good Quarterly Performance Priced In

Aug 02

These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely

Jun 12
These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely

Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled

May 13
Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled

Balchem EPS beats by $0.03, beats on revenue

Apr 30

Balchem: All Eyes On M&A And Autism Drug

Apr 26

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Ted Harris en comparación con los beneficios de Balchem?
FechaCompensación totalSalarioIngresos de la empresa
Mar 31 2024n/an/a

US$115m

Dec 31 2023US$6mUS$1m

US$109m

Sep 30 2023n/an/a

US$103m

Jun 30 2023n/an/a

US$99m

Mar 31 2023n/an/a

US$99m

Dec 31 2022US$12mUS$1m

US$105m

Sep 30 2022n/an/a

US$109m

Jun 30 2022n/an/a

US$109m

Mar 31 2022n/an/a

US$102m

Dec 31 2021US$6mUS$1m

US$96m

Sep 30 2021n/an/a

US$93m

Jun 30 2021n/an/a

US$90m

Mar 31 2021n/an/a

US$88m

Dec 31 2020US$5mUS$1m

US$85m

Sep 30 2020n/an/a

US$83m

Jun 30 2020n/an/a

US$82m

Mar 31 2020n/an/a

US$81m

Dec 31 2019US$4mUS$915k

US$80m

Sep 30 2019n/an/a

US$80m

Jun 30 2019n/an/a

US$78m

Mar 31 2019n/an/a

US$78m

Dec 31 2018US$3mUS$800k

US$79m

Sep 30 2018n/an/a

US$100m

Jun 30 2018n/an/a

US$97m

Mar 31 2018n/an/a

US$94m

Dec 31 2017US$2mUS$700k

US$90m

Compensación vs. Mercado: La compensación total de Ted($USD5.89M) está por debajo de la media de empresas de tamaño similar en el mercado US ($USD8.44M).

Compensación vs. Ingresos: La compensación de Ted ha sido consistente con los resultados de la empresa en el último año.


CEO

Ted Harris (58 yo)

9.1yrs

Permanencia

US$5,889,707

Compensación

Mr. Theodore L. Harris, also known as Ted, has been the Chief Executive Officer and President at Balchem Corporation since April 28, 2015. He serves as an Independent Director of Pentair Plc since April 30...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Theodore Harris
Chairman9.1yrsUS$5.89m0.21%
$ 10.0m
Carl Bengtsson
Executive VP5.3yrsUS$1.78m0.061%
$ 3.0m
Hatsuki Miyata
Executive VP1.8yrsUS$1.12m0.018%
$ 850.7k
Martin Reid
Senior VP & Chief Supply Chain Officer3.3yrsUS$1.15m0.020%
$ 978.4k
Frederic Boned
Senior VP and GM of Human Nutrition & Health1.5yrsUS$1.14m0.016%
$ 800.3k
William Backus
VP & Chief Accounting Officer12.9yrsUS$960.42k0.018%
$ 889.5k
Michael Sestrick
Senior VP & CTO1.7yrssin datos0.021%
$ 1.0m
Jonathan Griffin
Senior Vice President of Corporate Developmentless than a yearUS$1.01m0.039%
$ 1.9m
M. Tignor
Senior VP & Chief Human Resources Officer2.3yrssin datos0.026%
$ 1.3m
Job L. Gunsteren
Senior VP & GM of Specialty Products1.7yrssin datossin datos

2.0yrs

Permanencia media

47yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de BCPC se considera experimentado (2 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Theodore Harris
Chairman9.1yrsUS$5.89m0.21%
$ 10.0m
Daniel Knutson
Independent Director6.3yrsUS$226.26k0.016%
$ 759.5k
David Fischer
Independent Director13.7yrsUS$211.26k0.043%
$ 2.1m
Matthew Wineinger
Lead Independent Director8.7yrsUS$231.26k0.019%
$ 926.9k
Olivier Rigaud
Independent Directorless than a yearUS$21.67k0.0017%
$ 81.0k
Joyce Lee
Independent Director4.7yrsUS$211.26k0.0086%
$ 417.4k
Kathleen Fish
Independent Director2.9yrsUS$218.76k0.0049%
$ 237.3k
Monica Vicente
Independent Directorless than a yearUS$21.67k0.0017%
$ 81.0k

5.5yrs

Permanencia media

58.5yo

Promedio de edad

Junta con experiencia: La junta directiva de BCPC se considera experimentada (5.4 años de antigüedad promedio).